awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35853714-00078EB5-3AF6-479F-88A0-D2D75C268D98
Q35853714-00078EB5-3AF6-479F-88A0-D2D75C268D98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35853714-00078EB5-3AF6-479F-88A0-D2D75C268D98
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.
P2860
Q35853714-00078EB5-3AF6-479F-88A0-D2D75C268D98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35853714-00078EB5-3AF6-479F-88A0-D2D75C268D98
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad16be429d26087b6968e376beae849e1ce1c394
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.